user

A Phase II multicenter trial to evaluate combination ipilimumab and high-dose IL-2 in patients with unresectable stage III and IV melanoma.

被引：7
|
作者：
Kaufman, Howard
Wang, Jiafeng
Curti, Brendan D.
Clark, Joseph
Ernstoff, Marc S.
Silk, Ann
Mehnert, Janice M.
Zloza, Andrew
Shih, Joe
McDermott, David F.
机构：
[1] Rush Univ, Med Ctr, Chicago, IL 60612 USA
[2] Rutgers Canc Inst New Jersey, New Brunswick, NJ USA
[3] Providence Canc Ctr, Earle A Chiles Res Inst, Portland, OR USA
[4] Loyola Univ, Med Ctr, Maywood, IL 60153 USA
[5] Dartmouth Hitchcock Med Ctr, Norris Cotton Canc Ctr, Lebanon, NH 03766 USA
[6] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.tps3095
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS3095
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Phase 2 trial of talabostat and cisplatin in patients with stage IV melanoma.
    Cunningham, C.
    Pavlick, A. C.
    Khan, K. D.
    Frenette, G.
    O'Day, S.
    Stephenson, J.
    Gonzalez, R.
    Yang, Z.
    Vrhovac, V.
    Uprichard, M. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 462S - 462S
  • [12] Peripheral and local predictive immune signatures identified in a phase II trial of ipilimumab with carboplatin/paclitaxel in unresectable stage III or stage IV melanoma
    Jamal, Rahima
    Lapointe, Rejean
    Cocolakis, Eftihia
    Thebault, Pamela
    Kazemi, Shirin
    Friedmann, Jennifer E.
    Dionne, Jeanne
    Cailhier, Jean-Francois
    Belanger, Karl
    Ayoub, Jean-Pierre
    Le, Huy
    Lambert, Caroline
    El-Hajjar, Jida
    van Kempen, Leon C.
    Spatz, Alan
    Miller, Wilson H., Jr.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [13] Sequential administration of high-dose interleukin-2 and ipilimumab in patients with metastatic melanoma.
    Patel, Sapna Pradyuman
    Milton, Denai
    Milhem, Mohammed M.
    Flaherty, Lawrence E.
    Hallmeyer, Sigrun
    Feun, Lynn G.
    Hauke, Ralph J.
    Cranmer, Lee D.
    Daniels, Gregory A.
    Doolittle, Gary C.
    Taback, Bret
    Morse, Michael
    Lutzky, Jose
    Sharfman, William Howard
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [14] Final results of a phase II multicenter trial of HF10, a replication-competent HSV-1 oncolytic virus, and ipilimumab combination treatment in patients with stage IIIB-IV unresectable or metastatic melanoma.
    Andtbacka, Robert Hans Ingemar
    Ross, Merrick I.
    Agarwala, Sanjiv S.
    Taylor, Matthew H.
    Vetto, John T.
    Neves, Rogerio Izar
    Daud, Adil
    Khong, Hung T.
    Ungerleider, Richard S.
    Tanaka, Maki
    Grossmann, Kenneth F.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [15] Phase II study of ipilimumab (IPI) in children and adolescents with unresectable stage III or IV malignant melanoma (MEL).
    Pappo, Alberto S.
    Bergeron, Christophe
    Gore, Lia
    Sender, Leonard S.
    Dunkel, Ira J.
    Herzog, Cynthia E.
    Brochez, Lieve
    Cruz, Ofelia
    Nysom, Karsten
    Berghorn, Elmer
    Simsek, Burcin
    Shen, Jun
    Geoerger, Birgit
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [16] Phase I/II trial of a PrimeBoost therapeutic vaccine in stage III/IV metastatic melanoma.
    Hawkins, R. E.
    Dangoor, A.
    Keilholz, U.
    Schadendorf, D.
    Harris, A.
    Ottensmeier, C.
    Smyth, J.
    Hoffmnan, K.
    Anderson, R.
    Pearce, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 460S - 460S
  • [17] A phase 2 trial of high-dose allovectin-7 in patients with advanced metastatic melanoma.
    Richards, J
    Bedikian, AY
    Gonzalez, R
    Atkins, MB
    Whitman, ED
    Lutzky, J
    Morse, MA
    Amatruda, T
    Galanis, E
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 712S - 712S
  • [18] A pilot trial of hu14.18-IL2 in patients with completely resectable recurrent stage III or stage IV melanoma.
    Albertini, Mark R.
    Ranheim, Erik
    Hank, Jacquelyn A.
    Zuleger, Cindy
    McFarland, Thomas
    Collins, Jennifer
    Clements, Erin
    Weber, Sharon M.
    Weigel, Tracey
    Neuman, Heather B.
    Hartig, Gregory K.
    Mahvi, David
    Henry, MaryBeth
    Gan, Jacek
    Yang, Richard
    Kim, KyungMann
    Gillies, Stephen
    Sondel, Paul M.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [19] Complete surgical resection of residual melanoma metastasis and survival in stage IV patients following high-dose IL-2 therapy
    Taback, B.
    Honeyman, J.
    Liu, C.
    DeRaffele, G.
    Kaufman, H. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [20] A randomized phase II study of ipilimumab (IPI) with carboplatin and paclitaxel (CP) in patients with unresectable stage III or IV metastatic melanoma (MM).
    Jamal, Rahima
    Belanger, Karl
    Friedmann, Jennifer Elisabeth
    Ayoub, Jean-Pierre M.
    Cocolakis, Eftihia
    Kazemi, Shirin
    Dionne, Jeanne
    Lambert, Caroline
    Le, H. B.
    Van Kempen, Leon
    Spatz, Alan
    Lapointe, Rejean
    Miller, Wilson H.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345